DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortality
Titel:
DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortality
Auteur:
Wudhikarn, Kitsada Pennisi, Martina Garcia-Recio, Marta Flynn, Jessica R. Afuye, Aishat Silverberg, Mari Lynne Maloy, Molly A. Devlin, Sean M. Batlevi, Connie Lee Shah, Gunjan L. Scordo, Michael Palomba, Maria Lia Dahi, Parastoo B. Sauter, Craig S. Santomasso, Bianca D. Mead, Elena Perales, Miguel-Angel